While Covid-19 has been the greatest global catastrophe since World War II, the unprecedented needs of humankind have imposed multiple changes in the healthcare and life sciences industries. The traditional supply chain models have been rapidly surpassed, scientific research made notable progress, the funds invested in the industries have soared and telemedicine has come to stay. The healthcare and life sciences industries have a new face and are exposed to challenges which were almost unknown up to very recent times. Those are some of the issues this session is going to address, with special emphasis on the role of policy-makers, regulators and lawyers.